by Singapore-MIT Alliance for Research and Technology A confocal microscopy image of macrophages treated with MTX (cyan) that have eaten bacteria (magenta). Credit: Singapore-MIT Alliance for Research and Technology (SMART) Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin, which...
